Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent.

Anthony Buisson,Maria Nachury, Thomas Guilmoteau,Romain Altwegg,Xavier Treton,Mathurin Fumery,Melanie Serrero, Eloïse Leclerc,Ludovic Caillo,Bruno Pereira,Aurélien Amiot,Guillaume Bouguen

Alimentary pharmacology & therapeutics（2023）

引用 4|浏览46

暂无评分

摘要

Tofacitinib and vedolizumab are effective in UC after failure of anti-TNF agents. However, tofacitinib seems more effective, especially in severe disease and primary failure to biologics.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要